An Exploratory Clinical Study of Nimotuzumab in Bladder - Sparing Chemoradiotherapy for Muscle - Invasive Bladder Cancer

NCT07053735 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Bladder (Urothelial, Transitional Cell) Cancer

Interventions

DRUG: Nimotuzumab and Radiotherapy

Sponsor

Peking University First Hospital